| 
																	
																	
																		 Sujatha Jagannathan
 
																		 Concepts  (160)
																		
																	 
																		Concepts are derived automatically from a person's publications. 
																			
																					
    Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
     | Name | Number of Publications | Most Recent Publication | Publications by All Authors | Concept Score | Why? | 
|---|
 | Muscular Dystrophy, Facioscapulohumeral | 10 | 2023 | 30 | 4.710 | Why? |  | Nonsense Mediated mRNA Decay | 7 | 2025 | 16 | 4.420 | Why? |  | Codon, Nonsense | 5 | 2025 | 44 | 3.170 | Why? |  | Homeodomain Proteins | 9 | 2023 | 504 | 1.870 | Why? |  | RNA, Messenger | 13 | 2025 | 2837 | 1.430 | Why? |  | Ribosomes | 4 | 2023 | 170 | 1.280 | Why? |  | Endoplasmic Reticulum | 5 | 2021 | 265 | 1.270 | Why? |  | RNA | 4 | 2023 | 924 | 1.070 | Why? |  | Protein Biosynthesis | 3 | 2023 | 430 | 0.970 | Why? |  | Recombinational DNA Repair | 1 | 2025 | 16 | 0.920 | Why? |  | Gene Knockout Techniques | 1 | 2025 | 116 | 0.890 | Why? |  | Genetic Techniques | 1 | 2024 | 64 | 0.860 | Why? |  | CRISPR-Cas Systems | 1 | 2025 | 123 | 0.840 | Why? |  | Exons | 2 | 2024 | 349 | 0.830 | Why? |  | Genes, Reporter | 1 | 2024 | 268 | 0.830 | Why? |  | Proteomics | 3 | 2023 | 1111 | 0.820 | Why? |  | Gene Expression Regulation | 7 | 2023 | 2615 | 0.790 | Why? |  | Polyribosomes | 3 | 2014 | 23 | 0.660 | Why? |  | Peptides | 2 | 2025 | 981 | 0.640 | Why? |  | Transcriptome | 3 | 2016 | 973 | 0.630 | Why? |  | Proteins | 3 | 2023 | 1012 | 0.600 | Why? |  | Codon, Terminator | 3 | 2025 | 25 | 0.580 | Why? |  | Drosophila melanogaster | 1 | 2019 | 228 | 0.550 | Why? |  | Myotonic Dystrophy | 1 | 2017 | 10 | 0.540 | Why? |  | Myoblasts | 2 | 2017 | 84 | 0.530 | Why? |  | HEK293 Cells | 5 | 2025 | 734 | 0.490 | Why? |  | RNA-Binding Proteins | 4 | 2023 | 424 | 0.480 | Why? |  | Transcription, Genetic | 3 | 2021 | 1458 | 0.430 | Why? |  | Protein Transport | 1 | 2014 | 443 | 0.400 | Why? |  | MicroRNAs | 1 | 2019 | 703 | 0.390 | Why? |  | Genes, Homeobox | 2 | 2023 | 50 | 0.390 | Why? |  | Genomics | 1 | 2016 | 790 | 0.360 | Why? |  | Cell Fractionation | 1 | 2011 | 56 | 0.350 | Why? |  | Peptide Chain Termination, Translational | 2 | 2025 | 9 | 0.340 | Why? |  | Models, Biological | 1 | 2016 | 1774 | 0.310 | Why? |  | Muscle, Skeletal | 5 | 2023 | 1699 | 0.300 | Why? |  | Humans | 22 | 2025 | 136899 | 0.270 | Why? |  | Mutation | 2 | 2017 | 3948 | 0.250 | Why? |  | DNA Ligase ATP | 1 | 2025 | 4 | 0.240 | Why? |  | Cytosol | 3 | 2021 | 227 | 0.230 | Why? |  | DNA End-Joining Repair | 1 | 2025 | 20 | 0.230 | Why? |  | RNA Stability | 2 | 2023 | 117 | 0.220 | Why? |  | DNA Breaks, Double-Stranded | 1 | 2025 | 42 | 0.220 | Why? |  | Gene Editing | 1 | 2025 | 80 | 0.220 | Why? |  | Transcription Factors | 2 | 2023 | 1715 | 0.210 | Why? |  | Serine-Arginine Splicing Factors | 1 | 2023 | 22 | 0.200 | Why? |  | Open Reading Frames | 1 | 2023 | 120 | 0.200 | Why? |  | Mammals | 1 | 2023 | 286 | 0.180 | Why? |  | Muscular Atrophy | 1 | 2022 | 83 | 0.180 | Why? |  | Unfolded Protein Response | 1 | 2021 | 58 | 0.180 | Why? |  | Cytoplasmic Granules | 1 | 2021 | 95 | 0.170 | Why? |  | Blotting, Western | 2 | 2014 | 1227 | 0.160 | Why? |  | Base Sequence | 1 | 2023 | 2180 | 0.160 | Why? |  | Stress, Physiological | 2 | 2021 | 444 | 0.150 | Why? |  | Muscle Fibers, Skeletal | 2 | 2018 | 216 | 0.150 | Why? |  | Cell Line | 3 | 2019 | 2847 | 0.140 | Why? |  | Cells, Cultured | 2 | 2016 | 4204 | 0.140 | Why? |  | Myoblasts, Skeletal | 1 | 2017 | 12 | 0.140 | Why? |  | HeLa Cells | 2 | 2021 | 640 | 0.140 | Why? |  | Trans-Activators | 2 | 2017 | 399 | 0.140 | Why? |  | Subcellular Fractions | 2 | 2014 | 82 | 0.140 | Why? |  | RNA, Double-Stranded | 1 | 2017 | 56 | 0.130 | Why? |  | Muscle Development | 1 | 2017 | 111 | 0.130 | Why? |  | Loss of Function Mutation | 1 | 2016 | 47 | 0.130 | Why? |  | Rhabdomyosarcoma | 1 | 2017 | 72 | 0.130 | Why? |  | Genetic Fitness | 1 | 2016 | 57 | 0.130 | Why? |  | Cell Plasticity | 1 | 2016 | 34 | 0.120 | Why? |  | Placenta | 1 | 2023 | 749 | 0.120 | Why? |  | Proto-Oncogene Proteins c-myc | 1 | 2017 | 138 | 0.120 | Why? |  | Ubiquitin-Protein Ligases | 1 | 2017 | 175 | 0.120 | Why? |  | RNA Splicing | 1 | 2017 | 268 | 0.120 | Why? |  | Alternative Splicing | 1 | 2017 | 227 | 0.120 | Why? |  | Signal Recognition Particle | 1 | 2014 | 9 | 0.110 | Why? |  | SEC Translocation Channels | 1 | 2014 | 10 | 0.110 | Why? |  | Retroelements | 1 | 2015 | 47 | 0.110 | Why? |  | Feedback, Physiological | 1 | 2015 | 78 | 0.110 | Why? |  | Protein Sorting Signals | 1 | 2014 | 21 | 0.110 | Why? |  | Animals | 4 | 2023 | 36915 | 0.110 | Why? |  | Biomarkers | 2 | 2023 | 4148 | 0.110 | Why? |  | Immunoenzyme Techniques | 1 | 2014 | 219 | 0.110 | Why? |  | Genetic Variation | 1 | 2019 | 986 | 0.110 | Why? |  | Genome, Human | 1 | 2016 | 422 | 0.110 | Why? |  | Sequence Analysis, RNA | 1 | 2016 | 451 | 0.110 | Why? |  | Fluorescent Antibody Technique | 1 | 2014 | 386 | 0.110 | Why? |  | Real-Time Polymerase Chain Reaction | 1 | 2014 | 344 | 0.100 | Why? |  | In Situ Hybridization, Fluorescence | 1 | 2014 | 319 | 0.100 | Why? |  | Epigenesis, Genetic | 1 | 2018 | 658 | 0.100 | Why? |  | Oligonucleotide Array Sequence Analysis | 1 | 2014 | 765 | 0.100 | Why? |  | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 974 | 0.100 | Why? |  | Antigen Presentation | 1 | 2012 | 216 | 0.090 | Why? |  | Cell Compartmentation | 1 | 2011 | 52 | 0.090 | Why? |  | Histocompatibility Antigens Class I | 1 | 2012 | 203 | 0.090 | Why? |  | Denaturing Gradient Gel Electrophoresis | 1 | 2011 | 1 | 0.090 | Why? |  | Chemical Fractionation | 1 | 2011 | 29 | 0.090 | Why? |  | Centrifugation | 1 | 2011 | 30 | 0.090 | Why? |  | RNA Transport | 1 | 2011 | 23 | 0.090 | Why? |  | Detergents | 1 | 2011 | 44 | 0.090 | Why? |  | Blotting, Northern | 1 | 2011 | 199 | 0.090 | Why? |  | Indicators and Reagents | 1 | 2011 | 109 | 0.090 | Why? |  | Cytoplasm | 1 | 2011 | 274 | 0.080 | Why? |  | Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 346 | 0.080 | Why? |  | Pregnancy | 1 | 2023 | 6715 | 0.080 | Why? |  | Cell Differentiation | 1 | 2017 | 1976 | 0.080 | Why? |  | Gene Expression Profiling | 1 | 2016 | 1769 | 0.080 | Why? |  | Microscopy, Fluorescence | 1 | 2011 | 402 | 0.080 | Why? |  | Apoptosis | 1 | 2017 | 2542 | 0.070 | Why? |  | Membrane Proteins | 1 | 2014 | 1167 | 0.070 | Why? |  | RNA Helicases | 2 | 2017 | 30 | 0.060 | Why? |  | Proteolysis | 2 | 2017 | 179 | 0.060 | Why? |  | Proteasome Endopeptidase Complex | 2 | 2015 | 156 | 0.050 | Why? |  | Adolescent | 1 | 2022 | 21402 | 0.050 | Why? |  | Dithiothreitol | 1 | 2021 | 17 | 0.050 | Why? |  | Dactinomycin | 1 | 2021 | 28 | 0.050 | Why? |  | Organelle Biogenesis | 1 | 2021 | 15 | 0.050 | Why? |  | Phenanthrenes | 1 | 2021 | 13 | 0.050 | Why? |  | Diterpenes | 1 | 2021 | 31 | 0.050 | Why? |  | Epoxy Compounds | 1 | 2021 | 33 | 0.050 | Why? |  | beta 2-Microglobulin | 1 | 2021 | 50 | 0.050 | Why? |  | Peptide Chain Initiation, Translational | 1 | 2021 | 44 | 0.040 | Why? |  | Single Molecule Imaging | 1 | 2021 | 37 | 0.040 | Why? |  | Heat-Shock Proteins | 1 | 2021 | 142 | 0.040 | Why? |  | Adult | 1 | 2022 | 37595 | 0.040 | Why? |  | Proteome | 1 | 2023 | 473 | 0.040 | Why? |  | Membrane Glycoproteins | 1 | 2021 | 501 | 0.040 | Why? |  | Chromatin Assembly Factor-1 | 1 | 2018 | 12 | 0.040 | Why? |  | Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2018 | 26 | 0.040 | Why? |  | Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2018 | 32 | 0.040 | Why? |  | MyoD Protein | 1 | 2017 | 35 | 0.030 | Why? |  | Eukaryotic Initiation Factor-4A | 1 | 2017 | 5 | 0.030 | Why? |  | Female | 2 | 2023 | 72703 | 0.030 | Why? |  | Ubiquitination | 1 | 2017 | 103 | 0.030 | Why? |  | Gene Silencing | 1 | 2018 | 195 | 0.030 | Why? |  | DEAD-box RNA Helicases | 1 | 2017 | 76 | 0.030 | Why? |  | Gene Expression | 1 | 2021 | 1505 | 0.030 | Why? |  | Nucleosomes | 1 | 2018 | 156 | 0.030 | Why? |  | Caspases | 1 | 2017 | 247 | 0.030 | Why? |  | Protein Domains | 1 | 2017 | 290 | 0.030 | Why? |  | RNA Interference | 1 | 2017 | 463 | 0.030 | Why? |  | Cell Death | 1 | 2017 | 370 | 0.030 | Why? |  | Transfection | 1 | 2017 | 948 | 0.030 | Why? |  | Down-Regulation | 1 | 2017 | 658 | 0.030 | Why? |  | RNA, Small Interfering | 1 | 2017 | 620 | 0.030 | Why? |  | Protein Stability | 1 | 2015 | 178 | 0.030 | Why? |  | Substrate Specificity | 1 | 2015 | 385 | 0.030 | Why? |  | Chromatin | 1 | 2018 | 517 | 0.030 | Why? |  | Cell Survival | 1 | 2017 | 1122 | 0.030 | Why? |  | Puromycin | 1 | 2012 | 10 | 0.030 | Why? |  | Monitoring, Immunologic | 1 | 2012 | 23 | 0.030 | Why? |  | Gene Expression Regulation, Developmental | 1 | 2018 | 854 | 0.030 | Why? |  | Tumor Suppressor Protein p53 | 1 | 2017 | 531 | 0.020 | Why? |  | Myelolipoma | 1 | 2011 | 1 | 0.020 | Why? |  | Membranes | 1 | 2011 | 20 | 0.020 | Why? |  | Plasmacytoma | 1 | 2011 | 16 | 0.020 | Why? |  | Immunity, Innate | 1 | 2017 | 832 | 0.020 | Why? |  | Metabolic Networks and Pathways | 1 | 2011 | 182 | 0.020 | Why? |  | Time Factors | 1 | 2017 | 6802 | 0.020 | Why? |  | Signal Transduction | 1 | 2017 | 5077 | 0.010 | Why? |  | Cell Line, Tumor | 1 | 2011 | 3396 | 0.010 | Why? |  | Mice | 1 | 2011 | 17775 | 0.010 | Why? |  | Male | 1 | 2017 | 67308 | 0.010 | Why? | 
 | 
																	
																		
																			
																					
    Jagannathan's Networks
 
Click the "See All" links for more information and interactive visualizations!
 Concepts  Derived automatically from this person's publications._ Co-Authors  People in Profiles who have published with this person._ Similar People  People who share similar concepts with this person._ 
            
                Same Department   
				People who are also in this person's primary department.
			 Physical Neighbors  People whose addresses are nearby this person._ |